Colleen Doyle

Colleen Doyle has a diverse work experience history. Colleen is currently serving as the Director of Audit and Remediation at Sage Therapeutics, where they are responsible for enhancing compliance audit capabilities, leading investigations, and maintaining accountability for remediation plans. Previously, they worked at New York University, where they held several roles including Director of Investigations and Analytics, Associate Director of Internal Audit, and Manager of Internal Audit. In these positions, they developed and managed continuous auditing and monitoring programs, conducted financial investigations, and enhanced operational efficiencies. Prior to their tenure at New York University, Colleen worked as a Commercial Finance Manager at Allergan (formerly known as Actavis plc and Forest Laboratories, Inc). Before that, they gained valuable experience and expertise at Forest Laboratories, Inc, where they completed departmental rotations in Internal Audit, US Commercial Marketing/Product Management, R&D Quality Assurance, and International Finance. Additionally, they assisted in FDA inspections and product development for two commercially approved products and gained international marketing experience. Colleen started their career at KPMG, working as a Forensic Senior Associate. Colleen later transitioned to KPMG US as an Associate.

Colleen Doyle holds a Bachelor of Business Administration degree with a concentration in Accounting and Information Systems from the University of Massachusetts. Colleen also attended Williamsville North, although the specific degree and field of study are not provided. Colleen Doyle has obtained certifications as a Certified Fraud Examiner from ACFE and as a Certified Internal Auditor, although the institutions and dates of obtaining these certifications are not specified.